We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+0.65%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.9B
AUM Growth
-$2.32B
Cap. Flow
-$2.03B
Cap. Flow %
-2.75%
Top 10 Hldgs %
22.54%
Holding
3,088
New
92
Increased
1,359
Reduced
1,564
Closed
46

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$60.7M
2
ADI icon
Analog Devices
ADI
+$46.1M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37.3M
4
MTCH icon
Match Group
MTCH
+$28.2M
5
GXO icon
GXO Logistics
GXO
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 23.91%
2 Financials 14.2%
3 Healthcare 13.07%
4 Consumer Discretionary 12.09%
5 Communication Services 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MC icon
1426
Moelis & Co
MC
$4.94B
$4.45M 0.01%
71,876
+1,013
+1% +$60.7K
TENB icon
1427
Tenable Holdings
TENB
$4.01B
$4.44M 0.01%
96,271
+3,611
+4% +$158K
TGTX icon
1428
TG Therapeutics
TGTX
$7.62B
$4.42M 0.01%
132,945
+2,222
+2% +$68.7K
RLJ icon
1429
RLJ Lodging Trust
RLJ
$1.69B
$4.41M 0.01%
296,919
+7,493
+3% +$108K
WABC icon
1430
Westamerica Bancorp
WABC
$1.37B
$4.39M 0.01%
78,068
-16,588
-18% -$932K
BEPC icon
1431
Brookfield Renewable
BEPC
$6.26B
$4.39M 0.01%
113,109
-3,962
-3% -$166K
PLMR icon
1432
Palomar
PLMR
$3.45B
$4.39M 0.01%
54,263
-5,209
-9% -$430K
ACI icon
1433
Albertsons Companies
ACI
$5.83B
$4.38M 0.01%
140,866
-10,984
-7% -$289K
BIPC icon
1434
Brookfield Infrastructure
BIPC
$4.85B
$4.38M 0.01%
109,838
+35,889
+49% +$1.57M
PATK icon
1435
Patrick Industries
PATK
$2.85B
$4.38M 0.01%
78,830
-12,819
-14% -$686K
TPTX
1436
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$4.37M 0.01%
65,769
+1,773
+3% +$126K
FOE
1437
DELISTED
Ferro Corporation
FOE
$4.36M 0.01%
214,551
-32,505
-13% -$674K
ORA icon
1438
Ormat Technologies
ORA
$6.65B
$4.36M 0.01%
65,403
+1,899
+3% +$131K
HNI icon
1439
HNI Corp
HNI
$3.59B
$4.35M 0.01%
118,427
-16,668
-12% -$645K
UCTT
1440
Ultra Clean Holdings
UCTT
$3.95B
$4.33M 0.01%
101,696
-15,065
-13% -$710K
MARA icon
1441
Marathon Digital Holdings
MARA
$3.9B
$4.33M 0.01%
136,976
+1,843
+1% +$59.9K
CASH icon
1442
Pathward Financial
CASH
$1.8B
$4.32M 0.01%
82,303
-12,321
-13% -$613K
LZB icon
1443
La-Z-Boy
LZB
$1.69B
$4.31M 0.01%
133,801
-19,356
-13% -$667K
PETS icon
1444
PetMed Express
PETS
$42.3M
$4.29M 0.01%
159,749
+67,948
+74% +$1.96M
RITM icon
1445
Rithm Capital
RITM
$5.69B
$4.27M 0.01%
388,506
-31,763
-8% -$326K
ESI icon
1446
Element Solutions
ESI
$9.23B
$4.26M 0.01%
196,646
-20,699
-10% -$472K
AVNS
1447
DELISTED
Avanos Medical
AVNS
$4.26M 0.01%
136,598
-17,279
-11% -$586K
NVRO
1448
DELISTED
NEVRO CORP.
NVRO
$4.26M 0.01%
36,602
+616
+2% +$80.6K
MYRG icon
1449
MYR Group
MYRG
$5.25B
$4.25M 0.01%
42,742
-6,567
-13% -$646K
ECPG icon
1450
Encore Capital Group
ECPG
$2.13B
$4.24M 0.01%
86,141
-14,064
-14% -$668K

Similar funds

RhumbLine Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, RhumbLine Advisers held 3,088 positions worth $73.9B, down 3% from $76.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q3 2021: portfolio turnover was 4.5%. RhumbLine Advisers opened 92 new positions and exited 46, leaving the 3,088-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2021 buy was GXO Logistics: 250,722 shares worth $19.7M.
  • RhumbLine Advisers added most to Moderna in Q3 2021, an estimated $60.7M increase.
  • RhumbLine Advisers's biggest Q3 2021 reduction was Microsoft, cutting an estimated $89.3M.
  • RhumbLine Advisers fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $77.4M.
  • RhumbLine Advisers's ten largest holdings make up 23% of its $73.9B portfolio in Q3 2021.
  • RhumbLine Advisers opened 92 new positions and closed 46 in Q3 2021.
  • RhumbLine Advisers's portfolio value fell 3% quarter-over-quarter to $73.9B.

Based on RhumbLine Advisers's 13F filing for Q3 2021, filed 12 Nov 2021.